| Host: |
E. coli |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-Human TNFSF12/TWEAK-No tag protein was developed from e. coli and has a target region of No tag. For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Immunoreactivity: |
Measured by its binding ability in a functional ELISA. Immobilized Human TNFSF12 at 2 Mu g/mL (100 Mu L/well) can bind Human TNFRSF12A with a linear range of 0.1-2.3 ng/mL.2. Measured in a cell proliferation assay using human umbilical vein endotheli |
| Immunogen: |
Recombinant Human TNFSF12/TWEAK Protein is produced by E. coli expression system. The target protein is expressed with sequence (Lys97-His249 ( N-Met) ) of human TWEAK/TNFSF12 (Accession #NP_003800.1) fused with no additional amino acid. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
